Advertise on podcast: New Retina Radio by Eyetube

Are patients with DR at higher risk for TDR, DME, vitreous hemorrhage, or blindness based on race or ethnicity ? Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and Rehan Hussain, MD, about a large retrospective cohort study examining more than 627,000 US patients with DR. The panel examines why Black and Hispanic patients faced significantly higher rates of adverse outcomes at  1 and 5 years after diagnosis and unpacks what confounding variables the study could not capture. They consider what these findings should mean for screening strategies, patient education, and the day-to-day management of high-risk diabetic patients in clinic.

Could GLP-1s originally designed for diabetes and weight loss influence the risk of developing wet AMD? In this episode of New Retina Radio Journal Club with VBS, host Barton Blackorby, MD, is joined by Katharine Talcott, MD, and Hong-Uyen Hua, MD, to discuss a large national cohort study examining the relationship between GLP-1s and AMD. They explore potential biologic mechanisms, how big-data analyses are shaping retina research, and what these findings could mean for future AMD studies.

In this episode of RetinaLive focused on UNITY® VCS|CS, Jay Sridhar, MD welcomes Steve Charles, MD, FACS, FICS, FASRS and Maria Berrocal, MD for an in-depth conversation on the evolution of vitreoretinal surgery. The panel discusses the historical context of surgical technology, practical considerations for fluidics and intraoperative control, and the importance of adapting techniques for complex cases. Through real-world examples and expert perspectives, listeners will gain valuable insights into surgical decision-making, efficiency and the future of surgical retinal procedures. For Important Product Information, visit unityvcs.com. Disclaimers: Featured surgeons are paid Alcon consultants. The views expressed are their own. 8:57: Compared to HYPERVIT 20K 10:53: 5,000 cSt sillicone oil through 25 Ga cannulas, 1,000 cSt silicone oil through 25 Ga cannulas, up to 80% faster flow rate, all gauges (23 Ga, 25 Ga and 27 Ga entry system), based on bench data 20:45: Compared to CONSTELLATION® Vision System. Based on bench data. References: Alcon Data on File, 2024. [REF-24615] Alcon Data on File, 2024. [REF-24379] Alcon Data on File, 2024. [REF-24576] UNITY VCS and CS User Manual Alcon Data on File, 2024. [REF-24644] Vasavada V, et al. Real-time dynamic intraocular pressure fluctuations during microaxial phacoemulsification using different aspiration flow rates and their impact on early postoperative outcomes: a randomized clinical trial. Journal of Cataract & Refractive Surgery. 2014:30(8);534-540. Vasavada, AR, et al. Impact of high and low aspiration parameters on postoperative outcomes of phacoemulsification randomized clinical trial. Journal of Cataract & Refractive Surgery. 2010:36(4);588-593. Alcon Data on File, 2024. [REF-24899] Alcon Data on File, 2024. [REF-25374] Alcon Data on File, 2025. [REF-28170] NGENUITY 3D Visualization System User Guide 1.5 Manual. Bergamo VC, Caiado RR, Maia A. Et al, role of vital dyes in chromovirectomy. Asia Pac J Ophthalmol. 2021;10(1):26-38. Alcon Data on File, 2024. [REF-25563] Sponsored by Alcon, Inc. © 2026 Alcon Inc.     02/26     US-UVC-2600032

Co-hosts David Fell, MD, and Justin C. Muste, MD, are joined by Danny Mammo, MD, and Sean Berkowitz, MD, MBA, to talk all things uveitis, including challenging (and rewarding!) cases. They discuss signs of uveitis masqueraders, when to consider a diagnostic vitrectomy, how to manage patients at risk of being lost to follow-up, and ways to manage endophthalmitis.

Katherine E. Talcott, MD, sits down with retina mentors Yoshihiro Yonekawa, MD, and Adrienne W. Scott, MD, to discuss various strategies mentors and programs can implement to better support trainees who hale from diverse economic backgrounds.

How did patients with PDR fare after being lost to follow-up for at least 1 year and then returning to the clinic? Kyle Kovacs, MD, is joined by Matt Starr, MD, and Nita Valikodath, MD, MS, to explore a recent paper that leveraged the power the IRIS Registry to assess real-world outcomes for this important subset of patients. 

Podcast co-hosts David Fell, MD, and Justin Muste, MD, are joined by Joshua H. Uhr, MD, and Arnulfo Garza-Reyes, MD, to share their experiences with scleral buckling. They discuss the utility of buckling for various cases, encircling bands versus elements, and tips for surgical success. 

Join Dr. Nemo Patel, Dr. Matthew Donovan, and Dr. Danny Mammo as they share real-world insights on how the next generation of retina specialists are optimizing their patient care by adopting FDA-approved therapies for appropriate patients. Together, they explore how to navigate patient selection, safety monitoring, and workflow integration—while maintaining efficiency and patient confidence. The conversation highlights how practices are evolving to meet the growing need for GA management, from staff training and patient education to effective collaboration with referring optometrists.Listen in to gain actionable strategies that you can implement in your practice today. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.

Are you ready to accelerate your understanding of retina care?Join Dr. Nemo Patel as he speaks with Dr. Patrick Staropoli, a fellow retina specialist and professional race car driver, in an engaging discussion about Geographic Atrophy (GA) secondary to AMD.In this episode, Dr. Staropoli shares how the principles of racing—split-second decision-making, teamwork, and maintaining focus under pressure—influence his approach to treating GA. Together, they'll explore the evolving GA treatment landscape and emphasize the critical role of early detection and timely referral. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.

Dr. Nemo Patel is joined by Drs. Sam Minaker and Has Al-khersan, who share lessons learned early in their careers about connecting with patients, setting expectations, and integrating therapy for geographic atrophy (GA) secondary to AMD into their respective practices. Together they address how to discuss complex diseases with patients, involve family members in treatment discussions, and build rapport through empathy and transparency. The conversation also highlights practical approaches for team training, workflow efficiency, and addressing real-world challenges in GA care. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.

What types of delays do Stargardt disease patients experience when it comes to diagnosis? And what are the implications for such delays? Alexis Warren, MD, is joined by Jesse Sengillo, MD, and Sruthi Arepalli, MD, to discuss findings from a recent paper quantifying delays in diagnosis and suggesting means by which such delays could be mitigated.

Podcast co-hosts David Fell, MD, and Justin Muste, MD, sit down with Wills Eye fellow Flavius Beca, MD, to discuss the highs and lows of fellowship training, including successful cases of uveitis, clinical pearls for pneumatic retinopexy, and the challenges of treating retinal tears and detachments with vitrectomy and scleral buckling.

How do we know when a retina fellow is truly ready for independent surgery? Nikisha Kothari, MD, moderates a discussion with Jesse Sengillo, MD, and Nicholas Farber, MD, about a new survey study comparing perspectives from fellowship program directors and recent graduates on surgical volumes, teaching tools, autonomy, and competency benchmarks. The group explores areas of agreement, gaps in current training, and the push for more systematic assessment models in retina training.

How should retina specialists integrate next-generation anti-VEGF agents into real-world DME care? In this episode of “Anti-VEGFs: The Next Generation,” David Miller, MD, speaks with Esther Kim, MD, and Ehsan Rahimy, MD, about first-line agent selection, when to transition to newer options, how to incorporate steroids thoughtfully, and crafting dosing strategies that balance durability, efficacy, and adherence for working-age patients—without overpromising outcomes.This editorially independent series is supported with advertising by Regeneron.

How should retina specialists integrate next-generation anti-VEGFs into everyday wet AMD care? In this episode of “Anti-VEGFs: The Next Generation,” David Miller, MD, speaks with Esther Kim, MD, and Ehsan Rahimy, MD, about real-world issues facing wet AMD care, such as navigating crowded drug fridges, attempting interval extensions, and switching from legacy agents to next-generations treatments.  This editorially independent series is supported with advertising by Regeneron.